Your session is about to expire
← Back to Search
Holter Device for Fetal Monitoring
Study Summary
This trial will test a new way to measure fetal heart activity, to see if it is as accurate as the current standard.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Not applicable.I am pregnant with one or two babies, between 32 weeks and full term.
- Group 1: Holter device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an opportunity to enroll in this clinical experiment?
"Correct. The public information on clinicaltrials.gov indicates that this medical trial, which went live on June 2nd 2017, is currently recruiting subjects. This study aims to enrol 50 individuals from 1 site."
Are people under the age of sixty eligible to participate in this trial?
"As per the eligibility requirements, individuals between 18 and 55 years old are invited to participate in this medical research."
What is the total sample size of this research endeavor?
"Affirmative. Clinicaltrials.gov details that this medical experiment, which was published on June 2nd 2017, is actively recruiting patients presently. 50 individuals must be recruited from 1 trial site for the research to progress."
Is there any way I can participate in this medical research?
"Qualified candidates must have fetal monitoring and be between 18-55 years old. This clinical trial is hoping to enrol a total of 50 participants."
Share this study with friends
Copy Link
Messenger